Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/27/2010CN1878762B Morpholine derivatives as norepinephrine reuptake inhibitors
10/27/2010CN1871005B 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/27/2010CN1860101B Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
10/27/2010CN1826118B Multiparticulates
10/27/2010CN1819996B Naphthylene derivatives as cytochrome P450 inhibitors
10/27/2010CN1812982B Benzodiazepine CGRP receptor antagonists
10/27/2010CN1720240B Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN1671381B Pramipexole once-daily dosage form
10/27/2010CN1668303B Selective estrogen receptor modulators containing a phenylsulfonyl group
10/27/2010CN1649568B Pharmaceutical compositions for the treatment of asthma
10/27/2010CN1617742B Methods for treating cancer by using tumor-derived dentrical cell inhibitory factor antagonist in combination with toll-like receptor agonist
10/27/2010CN1602290B Process for the synthesis of chirally pure beta -amino-alcohols
10/27/2010CN1585640B N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101874036A Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat
10/27/2010CN101874035A Novel sulfated oligosaccharide derivatives
10/27/2010CN101874034A Compounds and methods for the treatment of cancer
10/27/2010CN101874032A Novel naphthyridine derivative monohydrate and method for producing the same
10/27/2010CN101874031A Sirtuin modulating imidazothiazole compounds
10/27/2010CN101874030A Pyrrolidines and piperidines as orexin receptor antagonists
10/27/2010CN101874029A Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/27/2010CN101874028A 2-aza-bicyclo[3.3.0]octane derivatives
10/27/2010CN101874024A 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
10/27/2010CN101874023A Alkylthio pyrimidines as CRTH2 antagonists
10/27/2010CN101874022A Indazole acrylic acid amide compound
10/27/2010CN101874020A Piperidine derivatives as agonists of muscarinic receptors
10/27/2010CN101874018A N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
10/27/2010CN101873867A High concentration chitosan-nucleic acid polyplex compositions
10/27/2010CN101873861A Composition for preventing virus infection comprising poly-gamma-glutamic acid
10/27/2010CN101873860A Beta-glucan treatment of upper respiratory tract infection symptoms and psychological well-being
10/27/2010CN101873859A Transdermally absorptive preparation
10/27/2010CN101873858A A drug delivery system for the prevention of cerebral vasospasm
10/27/2010CN101873857A Mipo inhibitors for the treatment of huntington's disease and multiple system atrophy
10/27/2010CN101873856A A pharmaceutical composition comprising glabridin or glabridin derivatives for suppression of dendritic cell maturation
10/27/2010CN101873855A Preparation and a component intended to be added to a tobacco product
10/27/2010CN101873854A Laminins, derivatives, and compositions including same and method for their therapeutic use
10/27/2010CN101873853A Compound and use thereof in the treatment of amyloidosis
10/27/2010CN101873852A Methods and compounds for treating retinol-related diseases
10/27/2010CN101873850A Vaginal delivery system
10/27/2010CN101873799A 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the treatment of post-traumatic stress disorder
10/27/2010CN101873798A Concentrated aqueous azalide formulations
10/27/2010CN101873797A Compositions and methods for treatment of diabetic retinopathy
10/27/2010CN101871931A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related therto
10/27/2010CN101870944A Blood fat regulating healthcare wine and preparation method thereof
10/27/2010CN101870768A Polyethylene glycol derivatives of activated lactone compounds
10/27/2010CN101870740A Morchellaconica extracellular polysaccharide extractive and preparation method and application thereof
10/27/2010CN101870720A Preparation method of ursolic acid and application thereof to medicine treating tumor diseases
10/27/2010CN101870718A Preparation method of high-purity natural ursodesoxycholic acid and application thereof in medicament
10/27/2010CN101870701A Bergenin isopentene group derivative and preparation method and application thereof
10/27/2010CN101870696A N-aryl piperazine derivative having double activity of dopamine D2 and 5-HT2a
10/27/2010CN101870694A 8,8-disubstituted-13,13a-dihyrdroberberine derivative as well as pharmaceutical composition and application thereof
10/27/2010CN101870692A Novel piperazinyl pyridazine compounds
10/27/2010CN101870691A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
10/27/2010CN101870690A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/27/2010CN101870689A 3-(1-halogenated methylene) sulphur chromane-4-ketone compound as well as preparation method and application thereof
10/27/2010CN101870684A Scutellarin aglycone derivative for treating vascular dementia and preparation method and application thereof
10/27/2010CN101870676A 1-(2-oximido-2-phenylethyl)-3-phenyl-1H-pyrazol-5-ethyl formate derivative as well as preparation method and application thereof
10/27/2010CN101870671A Adamantly pyrrolidine derivative, and preparation and application thereof
10/27/2010CN101870647A Novel drimane compound for treating gastroenteritis disease
10/27/2010CN101869716A System for monitoring bacterial tumor treatment
10/27/2010CN101869715A Cell particles carrying interfering ribonucleic acid (RNA), preparation method and application thereof
10/27/2010CN101869712A Medicinal composition used for treating tumor by utilizing polymeric micelles of cyst anticancer drugs
10/27/2010CN101869711A Medicament composition containing diuretic antihypertensive medicament and biguanide antidiabetic medicament and applications thereof
10/27/2010CN101869709A Composite of peptic ulcer resisting medicaments and preparation method thereof
10/27/2010CN101869708A Medicament composition containing calcium channel blockers and biguanide antidiabetic medicine and application thereof
10/27/2010CN101869700A Chinese medicinal oral liquid for treating tumour and preparation method thereof
10/27/2010CN101869699A Preparation process of bone peptide soft capsule
10/27/2010CN101869698A Liniment with combination of Chinese medicine and western medicine for fire treatment and preparation method thereof
10/27/2010CN101869692A Curcumin self-microemulsion and preparation method thereof
10/27/2010CN101869687A Medicament for treating fatty liver and alcohol liver, and reducing blood lipid and aminotransferase
10/27/2010CN101869670A Anti-gout composition, preparation method and application thereof in preparation of anti-gout drugs
10/27/2010CN101869655A Quick-acting scarless burn and scald ointment
10/27/2010CN101869642A Chinese medicinal composition
10/27/2010CN101869641A External medicinal liquor plaster for treating rheumatic diseases
10/27/2010CN101869633A Enteric-coated medicament combination containing epigallocatechin gallate
10/27/2010CN101869630A Measurement method for content of atropine sulfate in traditional Chinese medicine suppository containing belladonna liquid extract
10/27/2010CN101869627A Medicament for treating empyrosis
10/27/2010CN101869623A Medicament for treating trichoepithelioma and preparation method thereof
10/27/2010CN101869619A Medicament for treating tinea corporis and preparation method thereof
10/27/2010CN101869616A Hair nourishing liquid and manufacturing method thereof
10/27/2010CN101869607A Spray for fulfilling functions of prevention and health care on uncomfortable joint caused by wind cold dampness and preparation method
10/27/2010CN101869601A External veterinary medicament
10/27/2010CN101869597A Medicinal composition
10/27/2010CN101869595A Preparation method and quality detection method of liquorice and gall oral liquid
10/27/2010CN101869593A Detection method of pill capable of dissipating phlegm and stopping coughing
10/27/2010CN101869578A External liniment for drawing pus out and diminishing inflammation
10/27/2010CN101869576A New application of fig polysaccharide
10/27/2010CN101869575A Modulation of WRN-mediated telomere-initiated cell signaling
10/27/2010CN101869574A Application of uabain for enhancing cellular sensitivity of non-small cell lung cancer (NSCLC)
10/27/2010CN101869573A Aqueous solution of silybin glucoside and external composition for skin
10/27/2010CN101869572A Composition containing biguanide antidiabetic medicament and ACEI (Angiotensin-Converting Enzyme Inhibitors) medicament and applications thereof
10/27/2010CN101869571A Doxycycline hydrochloride and rifampicin effervescent granules for livestock and poultry and preparation method thereof
10/27/2010CN101869570A Ciclesonide contained pharmaceutical composition for application to mucosa
10/27/2010CN101869569A Ready-to-use entecavir composite
10/27/2010CN101869568A Use of autophagy (B-cell apoptosis) inhibitor
10/27/2010CN101869567A Medicament composition containing biguanide antidiabetic medicament and sartan antihypertensive medicament and applications thereof
10/27/2010CN101869566A Composition containing small dose of biguanide antidiabetic medicament and statin lipid-lowering medicament and applications thereof
10/27/2010CN101869565A Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
10/27/2010CN101869564A Medicinal composition taking dextrotolperisone as active ingredient
1 ... 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 ... 7860